Detalles de la búsqueda
1.
ABCC3 Expressed by CD56dim CD16+ NK Cells Predicts Response in Glioblastoma Patients Treated with Combined Chemotherapy and Dendritic Cell Immunotherapy.
Int J Mol Sci
; 20(23)2019 11 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-31771235
2.
Expansion of effector and memory T cells is associated with increased survival in recurrent glioblastomas treated with dendritic cell immunotherapy.
Neurooncol Adv
; 1(1): vdz022, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-32642658
3.
Survival gain in glioblastoma patients treated with dendritic cell immunotherapy is associated with increased NK but not CD8+ T cell activation in the presence of adjuvant temozolomide.
Oncoimmunology
; 7(4): e1412901, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29632727
4.
The multidrug-resistance transporter Abcc3 protects NK cells from chemotherapy in a murine model of malignant glioma.
Oncoimmunology
; 5(5): e1108513, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-27467914
5.
Immunotherapy against the radial glia marker GLAST effectively triggers specific antitumor effectors without autoimmunity.
Oncoimmunology
; 1(6): 884-893, 2012 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23162756
Resultados
1 -
5
de 5
1
Próxima >
>>